Cardiology Update

APRIL 9, 2024

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). Here is our curated list of the top sessions.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations The Annals of Thoracic Surgery November 2018 Alice Wang Robotic Mitral Valve Repair in Older Individuals: An Analysis of The Society of Thoracic Surgeons Database The Annals of Thoracic Surgery November 2018 Mohamad Alaeddine Aortic clamping strategy (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Scott Rankin The Impact of Mitral Disease Etiology on Operative Mortality After Mitral Valve Operations The Annals of Thoracic Surgery November 2018 Alice Wang 1 Robotic Mitral Valve Repair in Older Individuals: An Analysis of The Society of Thoracic Surgeons Database The Annals of Thoracic Surgery November 2018 Mohamad Alaeddine 1 Aortic clamping (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52